I aligned RNA-Seq reads to the reference genome. However, reads that span splice junctions will not align. What is the best way to handle this? I've read that aligning to a reference transcriptome is not the answer. Any thoughts? Thanks!
-
-
You might want to try TopHat/Bowtie.
Alternatively, you can download all mRNA sequences from UCSC and align against that.
Sam -
Thanks for the suggestions...I would like to stick with BWA....downloading only RNA sequences will cause novel genes to not align correctly. Any other thoughts?Comment
-
Maybe SpliceMap?
You know, you could always try TopHat. It's not like sequencing data goes bad after so many alignments
Comment
-
So I used tophat 2 to align the data. I used multiple cores but ran it on the default settings.
I have tumor and normal samples (no replicates, single end).
My accepted_hits.bam for the normal samples is 479MB while the unmapped.bam file is 3.4 GB. I was wondering what I might be able to do about this? I am re-aligning the unaligned reads in BWA, but I'm not sure if this is the best approach. Any thoughts? There should not be so few mapped reads for this sample. The tumor samples had an unmapped.bam file of size 796 MB and an accepted_hits.bam file of size 479 MB. Although this is better, it still seems low.
The normals should actually be better than the tumors due to sample quality.
Thanks in advance for your help!Comment
-
Did you quality trim before running the alignment? If not and a lot of your reads deteriorated in quality toward the end, that could be the issue. You might also try blasting a couple of the unmapped reads just to ensure there's nothing weird going on.Comment
-
In that same vein, did you do any adaptor trimming? That might be an issue if you haven't.
SamComment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment